| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy
|
Wong, Peter K. K.
|
|
2018
|
20 |
10 |
p. 1-13
|
article
|
| 2 |
Brief Report on the 10th Meeting of the European Forum on Antiphospholipid Antibodies
|
Eschwège, Valérie
|
|
2018
|
20 |
10 |
p. 1-4
|
article
|
| 3 |
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
|
Sandigursky, Sabina
|
|
2018
|
20 |
10 |
p. 1-7
|
article
|
| 4 |
Induction Therapy for Lupus Nephritis: the Highlights
|
Ayoub, Isabelle
|
|
2018
|
20 |
10 |
p. 1-8
|
article
|
| 5 |
Obstetric Anti-phospholipid Syndrome: State of the Art
|
Gerardi, Maria Chiara
|
|
2018
|
20 |
10 |
p. 1-12
|
article
|
| 6 |
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
|
Zhao, Sizheng
|
|
2018
|
20 |
10 |
p. 1-10
|
article
|
| 7 |
Rheumatic Manifestations of Haemoglobinopathies
|
Hughes, Michael
|
|
2018
|
20 |
10 |
p. 1-9
|
article
|
| 8 |
Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)
|
Mendoza-Pinto, Claudia
|
|
2018
|
20 |
10 |
p. 1-7
|
article
|
| 9 |
Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)
|
Mendoza-Pinto, Claudia
|
|
|
20 |
10 |
|
article
|
| 10 |
The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy
|
Espinoza, Luis R.
|
|
2018
|
20 |
10 |
p. 1-7
|
article
|
Journal description